Percorrendo por Autor ABBADI, BRUNO L.

Ir para: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ou digite as primeiras letras:  
Mostrando regs. 1 a 8 de 8
Data de publicaçãoTítuloAutor(es)
2021Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolatesRIBEIRO, RUAN C.B.; DE MARINS, DANIEL B.; DI LEO, IRIS, et al
2021Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosisSIDRÔNIO, MARIA GABRIELLA S.; CASTELO BRANCO, ANA PAULA O.T.; ABBADI, BRUNO L., et al
2021Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosisSIDRÔNIO, MARIA GABRIELLA S.; CASTELO BRANCO, ANA PAULA O.T.; ABBADI, BRUNO L., et al
2017Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzymeMARTINELLI, LEONARDO K. B.; ROTTA, MARIANE; VILLELA, ANNE D., et al
2017Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzymeMARTINELLI, LEONARDO K. B.; ROTTA, MARIANE; VILLELA, ANNE D., et al
2018Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?ABBADI, BRUNO L.; RODRIGUES-JUNIOR, VALNÊS DA SILVA; DADDA, ADILIO DA SILVA, et al
2020Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapyRODRIGUES-JUNIOR, VALNÊS S.; VILLELA, ANNE D.; ABBADI, BRUNO L., et al
2018Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosisMURADÁS, THAÍS C.; ABBADI, BRUNO L.; VILLELA, ANNE D., et al